Table 1 Characteristics of patients.
n (male/female) | 1080 (774/306) |
Age (years) | 74 (67–79) |
Duration of diabetes (years) | 7.5 (4–12) |
Body mass index (kg/m2) | 24.6 (22.1–27.4) |
Systolic blood pressure (mmHg) | 131 (117–143) |
Diastolic blood pressure (mmHg) | 72 (61.3–82) |
Heart rate (beat per minutes) | 75 (66–86) |
Hemoglobin A1c (%) | 6.8 (6.3–7.7) |
Total cholesterol (mg/dl) | 170 (146–203) |
Low-density lipoprotein cholesterol (mg/dl) | 94.2 (68.2–121.15) |
Triglycerides (mg/dl) | 116 (87–166) |
Uric acid (mg/dl) | 5.5 (4.4–6.8) |
Creatinine (mg/dl) | 0.96 (0.79–1.40) |
Smoking status (never/past/recent) | 448/234/398 |
Hypertension (−/ +) | 298/782 |
History of CVD (angina or myocardial infarction/stroke/peripheral artery disease) | 765/298/161 |
Previous revascularization history (−/ +) | 595/485 |
Perfusion index (%) | 2.6 (1.1–4.3) |
Anti-platelet therapies (−/ +) | 153/927 |
Renin-angiotensin system inhibitor (−/ +) | 484/596 |
Glucagon-like peptide-1 agonists (−/ +) | 984/116 |
Sodium-glucose cotransporter 2 inhibitor (−/ +) | 983/97 |
Statin (−/ +) | 476/604 |
